JENNIFER RANKIN: Open Payments
NPI 1356062665 · ARNOLD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,241 in 70 payments from 20 companies in 2025. Trend: 2023 $626 · 2024 $1,676 · 2025 $1,241
Food & beverage: $1,241
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $273 |
| AstraZeneca Pharmaceuticals LP | 8 | $189 |
| Lilly USA, LLC | 7 | $144 |
| Novo Nordisk Inc | 9 | $142 |
| Exact Sciences Corporation | 4 | $79 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Tris Pharma Inc | 3 | $51 |
| Lundbeck LLC | 2 | $46 |
| Amgen Inc. | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
Products named: MOUNJARO, VRAYLAR, AIRSUPRA, QULIPTA, Ozempic, The Cologuard Plus Collection Kit, UBRELVY, BREZTRI.
Industry payments across MO — which companies pay providers there.
